Decision-Aiding System Improves Clinical Trial Performance
The CCI-CPP collaborative team announces the newest release of Country Allocation Planner? (CAP), a Web-based system for global clinical trial planning.??
DECISION-AIDING SYSTEM IMPROVES CLINICAL TRIAL PERFORMANCE
ATLANTA, GA June 19, 2008 – The CCI-CPP collaborative team announces the newest release of Country Allocation Planner™ (CAP), a Web-based system for global clinical trial planning. CAP improves clinical trial enrollment forecasting and the process of selecting countries for study participation by facilitating robust, unlimited and real-time “what if” scenario modeling.
“Fundamentally, CAP helps study planning teams forecast realistic enrollment times and select the optimum mix of countries and subject contributions to meet key operational objectives, like cycle time and cost,” says Beth Harper of Clinical Performance Partners, Inc.
The design for the system is a result of a collaborative effort between Core Concept, Inc., specialists in software, simulation and decision support, and Clinical Performance Partners, Inc. a provider of enrollment and site performance management services. CAP uses industry data on disease prevalence as well as internal company benchmark data, and then incorporates enrollment feasibility data to plan, manage and update enrollment projections.
CAP’s linear programming and advanced data modeling capabilities allow planning across multiple parameters, such as number of countries and investigative sites, enrollment rate, subject contribution, disease prevalence, and per subject cost. This breadth of enrollment planning is generally not feasible for most users engaged in global clinical trials.
“Our user-friendly system ensures that all available information and advanced analysis techniques are combined to provide the sponsor or contract research organization (CRO) with insight into the best possible scenarios for enrollment success,” states Rob Andes, Executive Vice President of Core Concept. CAP does not make decisions, rely on team assumptions to make arbitrary enrollment projections or force the user to adhere to a set workflow.
Want to learn more or schedule a demo? Contact Rob Andes at 678/772-7181 or email [email protected].
About Clinical Performance Partners - CPP is a consulting firm dedicated to designing and implementing innovative and practical solutions for improving site performance and accelerating clinical trials results for the Life Sciences Industry. www.clinicalperformancepartners.com
About Core Concept, Inc. – CCI is a software product company specializing in the development of advanced decision support systems for the analysis, forecasting, planning and management of clinical trials and payor management. www.coreconcept.com
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
MariTide Shows Up to 20% Weight Loss in Phase II Trial for Obesity, Type 2 Diabetes
June 24th 2025In a Phase II trial, Amgen’s investigational therapy MariTide (maridebart cafraglutide) delivered significant, sustained weight loss of up to 20% in adults with obesity, with or without type 2 diabetes, alongside notable improvements in glycemic control, supporting its advancement to Phase III studies as a potential once-monthly treatment option.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
